Insider · CIK 0001576103

Maetzel Andreas

Reports to the SEC for 2 companies · CARY, NC

sec.gov

Transactions

Companies

Filings

CIK

0001576103

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-26	KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Senior Vice President, Medical	AAward	+25K sh	—	—	25,000
2021-04-29	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	+12.9K sh	$7.91	+$102K	12,856
2021-04-29	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	+14.7K sh	$8.21	+$120K	27,518
2021-04-29	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	+13.4K sh	$16.08	+$215K	40,886
2021-04-29	KalVista Pharmaceuticals, Inc.S Sale	Senior Vice President, Medical	SSale	−40.9K sh	$25.04	−$1.02M	0
2021-04-29	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	−12.9K sh	—	—	0
2021-04-29	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	−14.7K sh	—	—	6,038
2021-04-29	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	−13.4K sh	—	—	7,332
2021-04-28	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	+36.1K sh	$7.91	+$286K	36,127
2021-04-28	KalVista Pharmaceuticals, Inc.S Sale	Senior Vice President, Medical	SSale	−10.6K sh	$25.50	−$271K	25,507
2021-04-28	KalVista Pharmaceuticals, Inc.S Sale	Senior Vice President, Medical	SSale	−15K sh	$25.25	−$379K	10,507
2021-04-28	KalVista Pharmaceuticals, Inc.S Sale	Senior Vice President, Medical	SSale	−10K sh	$25.54	−$255K	507
2021-04-28	KalVista Pharmaceuticals, Inc.S Sale	Senior Vice President, Medical	SSale	−507 sh	$25.65	−$13K	0
2021-04-28	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	−36.1K sh	—	—	12,856
2021-04-27	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	+11K sh	$7.91	+$87.1K	11,017
2021-04-27	KalVista Pharmaceuticals, Inc.S Sale	Senior Vice President, Medical	SSale	−11K sh	$25.79	−$284K	0
2021-04-27	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	−11K sh	—	—	48,983
2021-02-07	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Senior Vice President, Medical	AAward	+10K sh	—	—	10,000
2021-02-07	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Senior Vice President, Medical	AAward	+10K sh	—	—	10,000
2020-12-16	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Senior Vice President, Medical	AAward	+20K sh	—	—	20,000
2019-05-15	KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Senior Vice President, Medical	AAward	+9,000 sh	—	—	9,000
2019-04-05	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	+5,000 sh	$7.91	+$39.6K	5,000
2019-04-05	KalVista Pharmaceuticals, Inc.S Sale	Senior Vice President, Medical	SSale	−5,000 sh	$30.00	−$150K	0
2019-04-05	KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Senior Vice President, Medical	MExercise/Conversion	−5,000 sh	—	—	60,000
2018-09-18	KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Senior Vice President, Medical	AAward	+20.7K sh	—	—	20,700
2018-06-04	KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Senior Vice President, Medical	AAward	+20.7K sh	—	—	20,700
2017-03-08	KalVista Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Senior Vice President, Medical	AAward	+65K sh	—	—	65,000
2014-02-03	CORNERSTONE THERAPEUTICS INCD Disposition to Issuer	VP, Clinical and Regulatory	DDisposition to Issuer	−25K sh	$9.50	−$238K	0
2014-02-03	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)D Disposition to Issuer	VP, Clinical and Regulatory	DDisposition to Issuer	−25K sh	$1.10	−$27.5K	0
2013-05-06	CORNERSTONE THERAPEUTICS INCA Award	VP, Clinical and Regulatory	AAward	+25K sh	—	—	25,000
2013-05-06	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)A Award	VP, Clinical and Regulatory	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
May 284
Maetzel Andreas0001209191-21-036585
SEC(opens sec.gov)
Apr 294
Maetzel Andreas0001209191-21-029137
SEC(opens sec.gov)
Feb 84
Maetzel Andreas0001209191-21-008665
SEC(opens sec.gov)
Dec 184
Maetzel Andreas0001209191-20-064476
SEC(opens sec.gov)

Companies

Address

1255 CRESCENT GREEN DRIVE SUITE 250

CARY, NC, 27518